Steven A. Ledger

CIK: 0001090206

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SER

Serina Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

SER
Serina Therapeutics, Inc.
May 26, 2026
Award(A)
Direct
10.1K shares at avg. $1.93$19K
SER
Serina Therapeutics, Inc.
May 21, 2026
Award(A)
Stock Option (right to buy)
Direct
380.8K shares-
SER
Serina Therapeutics, Inc.
Feb 3, 2026
Award(A)
Stock Option (right to buy)
Direct
230.1K shares-
SER
Serina Therapeutics, Inc.
Mar 28, 2025
Other(J)
Direct
95.7K shares-
SER
Serina Therapeutics, Inc.
Sep 9, 2024
Award(A)
Stock Option (right to buy)
Direct
376.4K shares-

		Type	Shares	Price		Ownership
May 26, 2026	SER Serina Therapeutics, Inc.	Award(A)	10,100	$1.93	$19,493	Direct
May 21, 2026	SER Serina Therapeutics, Inc.	Award(A) Stock Option (right to buy)	380,825	-	-	Direct
Feb 3, 2026	SER Serina Therapeutics, Inc.	Award(A) Stock Option (right to buy)	230,100	-	-	Direct
Mar 28, 2025	SER Serina Therapeutics, Inc.	Other(J)	95,730	-	-	Direct
Sep 9, 2024	SER Serina Therapeutics, Inc.	Award(A) Stock Option (right to buy)	376,388	-	-	Direct

1-5 of 5 transactions

About LEDGER STEVEN A

LEDGER STEVEN A (SEC CIK 0001090206) files insider reports with the SEC as Chief Executive Officer of Serina Therapeutics, Inc. (SER).

Signal8 holds 5 ownership filings by LEDGER STEVEN A, all Form 4s, filed between Sep 11, 2024 and May 27, 2026. Those filings report 5 transactions, from Sep 9, 2024 to May 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LEDGER STEVEN A's filings is in HUNTSVILLE, AL.

Recent filings by LEDGER STEVEN A

May 26, 2026: Grant or award of SER shares (Form 4, code A).
May 21, 2026: Grant or award of SER derivative securities (Form 4, code A).
Feb 3, 2026: Grant or award of SER derivative securities (Form 4, code A).
Mar 28, 2025: Other transaction of SER shares (Form 4, code J).
Sep 9, 2024: Grant or award of SER derivative securities (Form 4, code A).

Other insiders filing for Serina Therapeutics, Inc. (SER)

Simon Farrell, Director
Brannan Stephen K., Director
Venkatesan Jay, Director
Bailey Gregory, Director
WILSON KAREN J, Director
Marshall Richard Peter, Director

How to read Form 4 transaction codes